SCHEMBL3785484

SCHEMBL3785484

CCc1ccc(C(=O)O)c([N+](=O)[O-])c1F

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.42
TDP1 Q9NUW8 2/20 0.42
CYP3A4 P08684 1/20 0.42
ALOX15 P16050 1/20 0.42
HTT P42858 2/20 0.40
TP53 P04637 1/20 0.40
GABRP O00591 2/20 0.39
GABRD O14764 2/20 0.39
GABRA1 P14867 2/20 0.39
GABRB1 P18505 2/20 0.39
GABRG2 P18507 2/20 0.39
GABRB3 P28472 2/20 0.39
GABRA5 P31644 2/20 0.39
GABRA3 P34903 2/20 0.39
GABRA2 P47869 2/20 0.39
GABRB2 P47870 2/20 0.39
GABRA4 P48169 2/20 0.39
GABRE P78334 2/20 0.39
GABRA6 Q16445 2/20 0.39
GABRG1 Q8N1C3 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27267409 0.84 HCAR3 (0.43) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL8403333 0.82 ALDH1A1 (0.45) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL20594425 0.81 TSHR (0.47) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL21932523 0.80 TSHR (0.50) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL28352668 0.79 TSHR (0.45) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL6204506 0.79 CES2 (0.45) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL5248959 0.78 GABRP (0.42) ALDH1A1ALOX15HTTGABRPGABRD
SCHEMBL4876434 0.78 HTT (0.38) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL7941828 0.77 TP53 (0.43) ALDH1A1TDP1CYP3A4ALOX15HTT
SCHEMBL9903207 0.76 POLB (0.36) ALDH1A1TDP1HTTCYP1A2PDK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100298302-A1 NOVEL PROTEIN KINASE MODULATORS SENHWA BIOSCIENCES, INC. (TW) 2010-11-25 US disclosed
WO-2010135571-A1 NOVEL PROTEIN KINASE MODULATORS CYLENE PHARMACEUTICALS, INC. (US) 2010-11-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100298302-A1 NOVEL PROTEIN KINASE MODULATORS PIM2, PIM1, PIM3 ALDH1A1 4648/4885TDP1 1857/4885CYP3A4 3249/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.